In the News

Dealmakers adapt to U.S. tax-inversion restrictions – Lexpert

In a Lexpert article exploring how advance knowledge of the U.S. Treasury Departments anti-inversion regulations has lessened their impact, Davies partner Hillel Rosen discusses the M&A boom in life sciences. Were reading about inversion, but the real story is that M&A is the new R&D,” says Hillel. It incorporates the notion that you can be a pharma company without spending a dollar in research.

Related

Selected US Tax Developments

Jan. 31, 2025 - First published by the Canadian Tax Foundation in (2024) 72:4 Canadian Tax Journal. Treaty Provides Unique Benefits To Canadians Migrating To The United States Canadians who emigrate to the United States or elsewhere face many decisions and considerations...

>